Panel Recommends New Zoster Vaccine as First-Line Treatment

Share this content:
Panel Recommends New Zoster Vaccine as First-Line Treatment
Panel Recommends New Zoster Vaccine as First-Line Treatment

THURSDAY, Oct. 26, 2017 (HealthDay News) -- In a close 8-7 vote, the Advisory Committee on Immunization Practices recommended that Shingrix be chosen over Zostavax as the herpes zoster vaccine of choice in adults aged 50 and older, the Washington Post reported.

Previously, vaccination had been recommended only for those aged 60 and older. The panel went even further and recommended that anyone who has been vaccinated with the Zostavax vaccine be re-vaccinated with the Shingrix vaccine, the Post reported. In total, more than 40 million people will be affected by the new recommendations, the newspaper said.

The U.S. Food and Drug Administration had just approved Shingrix last Friday based on a study from its maker, GlaxoSmithKline. That research found Shingrix protected about 90 percent of patients, but Zostavax protected only 50 percent of patients. Shingrix requires two shots, while Zostavax requires only one shot.

"This represents a major advance for people who want to be protected against the disease and its complications," Kathleen Dooling, M.D., M.P.H., a medical officer with the U.S. Centers for Disease Control and Prevention, told the Post.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

U.S. High School Students Report Sport-Linked Concussion

U.S. High School Students Report Sport-Linked Concussion

Overall, 15.1 percent of students reported having at least one concussion in the previous 12 months

Corneal Abnormalities Seen With Down Syndrome

Corneal Abnormalities Seen With Down Syndrome

More than 70 percent of patients in Down syndrome group had traits compatible with keratoconus

Many Childhood CA Survivors Not Concerned About Future Health

Many Childhood CA Survivors Not Concerned About Future ...

Even among those exposed to high radiation doses, one-third not concerned about developing cancer

is free, fast, and customized just for you!




Already a member?

Sign In Now »